This proposal requests continuing support for a Chemistry-Biology Interface (CBI) Training Program at Vanderbilt University. Twenty eight faculty preceptors from five departments in the College of Arts and Sciences and in the School of Medicine will serve as mentors for the Program. Significant biological training will be provided to students receiving in-depth training in synthetic/mechanistic chemistry and significant training in synthetic/mechanistic chemistry will be provided to students receiving in-depth training in the biological sciences. Highlights of the training program include a chemical biology curriculum, elective courses for specialized training, and an interactive seminar series in chemical biology, an annual research retreat and an in-depth laboratory research experience. Students will be well-grounded in a core discipline and sufficiently well-trained in complementary fields to allow them to work effectively in a multi-disciplinary environment. Support for eight trainees is requested. Trainees will obtain Ph.D. degrees working with preceptors in the Departments of Biochemistry (6 preceptors), Chemistry (13 preceptors), Microbiology and Immunology (1 preceptor), Molecular Physiology and Biophysics (1 preceptor) and Pharmacology (7 preceptors). Lay language description: Advances in biotechnology, drug discovery and related life science fields require the exchange of ideas and knowledge between the fields of chemistry and biology. One objective of this training program is to develop a future generation of scientists who apply an understanding of chemistry and biology to biomedical related problems.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM065086-09
Application #
8080878
Study Section
Special Emphasis Panel (ZGM1-BRT-5 (TG))
Program Officer
Fabian, Miles
Project Start
2002-07-01
Project End
2013-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
9
Fiscal Year
2011
Total Cost
$265,128
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Biochemistry
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Craft, Kelly M; Townsend, Steven D (2018) The Human Milk Glycome as a Defense Against Infectious Diseases: Rationale, Challenges, and Opportunities. ACS Infect Dis 4:77-83
Choby, Jacob E; Grunenwald, Caroline M; Celis, Arianna I et al. (2018) Staphylococcus aureus HemX Modulates Glutamyl-tRNA Reductase Abundance To Regulate Heme Biosynthesis. MBio 9:
Choby, Jacob E; Buechi, Hanna B; Farrand, Allison J et al. (2018) Molecular Basis for the Evolution of Species-Specific Hemoglobin Capture by Staphylococcus aureus. MBio 9:
Morgan, Amanda J; Kingsley, Philip J; Mitchener, Michelle M et al. (2018) Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain. ACS Chem Neurosci 9:1552-1559
Cassat, James E; Moore, Jessica L; Wilson, Kevin J et al. (2018) Integrated molecular imaging reveals tissue heterogeneity driving host-pathogen interactions. Sci Transl Med 10:
Kovtun, Oleg; Tomlinson, Ian D; Bailey, Danielle M et al. (2018) Single Quantum Dot Tracking Illuminates Neuroscience at the Nanoscale. Chem Phys Lett 706:741-752
Chambers, Schuyler A; DeSousa, Jenna M; Huseman, Eric D et al. (2018) The DARK Side of Total Synthesis: Strategies and Tactics in Psychoactive Drug Production. ACS Chem Neurosci 9:2307-2330
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Kozek, Krystian A; Du, Yu; Sharma, Swagat et al. (2018) Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels. ACS Chem Neurosci :
Ackerman, Dorothy L; Craft, Kelly M; Doster, Ryan S et al. (2018) Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii. ACS Infect Dis 4:315-324

Showing the most recent 10 out of 138 publications